Stereotaxis, Inc. · AMEX:STXS

Dr. Nathan Fischel reported a 15.30% stake in Stereotaxis, Inc. (Schedule 13D/A)

Event Nov 9, 2026 · Filed Nov 12, 2026

Dr. Nathan Fischel reported a 15.30% stake in Stereotaxis, Inc., 15,628,395 shares, with active intent on Nov 9, 2026. Filed Nov 12, 2026 (Schedule 13D/A).

Stake
15.30%
Shares
15,628,395
Intent
Active
What changed
Stake changed
Filed together
5 holders

The filing in full

HolderStakeShares
DAFNA Capital Management, LLC15.10%15,333,446
Dr. Nathan Fischel15.30%15,628,395
Dr. Fariba Ghodsian15.10%15,333,446
DAFNA LifeScience, L.P.7.90%8,005,938
DAFNA LifeScience Select, L.P.7.30%7,327,508

Source

Download original · View original at SEC

Related